The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giles, I.
Right arrow Articles by Rahman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giles, I.
Right arrow Articles by Rahman, A.
The Journal of Immunology, 2006, 177: 1729-1736.
Copyright © 2006 by The American Association of Immunologists

Arginine Residues Are Important in Determining the Binding of Human Monoclonal Antiphospholipid Antibodies to Clinically Relevant Antigens1

Ian Giles2,*,{dagger},{ddagger}, Nancy Lambrianides*,{dagger}, Nisha Pattni*,{dagger}, David Faulkes{dagger}, David Latchman{dagger}, Pojen Chen§, Silvia Pierangeli{ddagger}, David Isenberg* and Anisur Rahman*,{dagger}

* Centre for Rheumatology, Department of Medicine, University College, London, United Kingdom; {dagger} Medical Molecular Biology Unit, Institute of Child Health, University College, London, United Kingdom; {ddagger} Department of Microbiology, Immunology and Biochemistry, Morehouse School of Medicine, Atlanta, GA 30310; and § Department of Medicine, Division of Rheumatology, University of California, Los Angeles, CA 90095

In the antiphospholipid syndrome (APS), antiphospholipid Abs (aPL) bind to anionic phospholipids (PL) and various associated proteins, especially beta2-glycoprotein I (beta2GPI) and prothrombin. In the present study, we show that altering specific Arg residues in the H chain of a human pathogenic beta2GPI-dependent aPL, IS4, has major effects on its ability to bind these clinically important Ags. We expressed whole human IgG in vitro by stable transfection of Chinese hamster ovary cells with expression plasmids containing different VH and VL sequences. VH sequences were derived from IS4 by altering the number of Arg residues in CDR3. VL sequences were those of IS4, B3 (anti-nucleosome Ab), and UK4 (beta2GPI-independent aPL). Binding of the expressed H/L chain combinations to a range of anionic, neutral, and zwitterionic PL, as well as prothrombin, beta2GPI, dsDNA, and chicken OVA, was determined by ELISA. Of four Arg residues in IS4VH CDR3 substituted to Ser, two at positions 100 and 100g, reduced binding to all Ags, while two at positions 96 and 97 reduced binding to beta2GPI but increased or decreased binding to different PL. Eleven of 14 H/L chain combinations displayed weak binding to OVA with Arg to Ser replacements of all four Arg residues enhancing binding to this Ag. Only one H/L chain combination bound neutral PL and none bound dsDNA; hence, these effects are particularly relevant to Ags important in antiphospholipid syndrome. We hypothesize that these four Arg residues have developed as a result of somatic mutations driven by an Ag containing both PL and beta2GPI.




This article has been cited by other articles:


Home page
ScienceHome page
R. A. Keenan, A. De Riva, B. Corleis, L. Hepburn, S. Licence, T. H. Winkler, and I.-L. Martensson
Censoring of Autoreactive B Cell Development by the Pre-B Cell Receptor
Science, August 1, 2008; 321(5889): 696 - 699.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M.-Y. Zhang, B. K. Vu, A. Choudhary, H. Lu, M. Humbert, H. Ong, M. Alam, R. M. Ruprecht, G. Quinnan, S. Jiang, et al.
Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Human Monoclonal Antibody That Recognizes a Novel Conformational Epitope on gp41 and Lacks Reactivity against Self-Antigens
J. Virol., July 15, 2008; 82(14): 6869 - 6879.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
I Giles and C Putterman
Autoantibodies and other biomarkers - pathological consequences (1)
Lupus, March 1, 2008; 17(3): 241 - 246.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.